brain cancer

A 13-year-old has reportedly become the first patient cured of DIPG, an aggressive and almost universally fatal childhood brain cancer. The announcement, described as a world first, is drawing attention because DIPG has resisted decades of treatment efforts, with most children diagnosed surviving less than a year. If confirmed, it could mark a turning point in pediatric cancer research.

Researchers report that a 'proliferative pause' — a dormant phase cancer cells enter before spreading — may offer a critical window to intervene and stop brain metastasis before it takes hold. The findings, covered by Inside Precision Medicine, suggest targeting cells during this quiet period could prevent secondary brain tumours, a major cause of death in patients with advanced cancers such as breast cancer and melanoma.